Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/27/2011WO2011132713A1 Lipid membrane structure with nuclear transferability
10/27/2011WO2011132672A1 Method for stabilizing functional nucleic acids
10/27/2011WO2011132667A1 Pcr test method which eliminates false-negatives, and primer used in the same
10/27/2011WO2011132444A1 Modified carbonyl reductase, gene thereof, and method of producing optically active alcohols using these
10/27/2011WO2011132127A1 Enhanced methods for gene regulation in plants
10/27/2011WO2011131707A1 ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
10/27/2011WO2011131611A1 Modulating xrn1
10/27/2011WO2011131420A1 Biocatalytic oxidation process with alkl gene product
10/27/2011WO2011131407A1 Antibodies against human csf-1r and uses thereof
10/27/2011WO2011131371A1 Lipid binding nucleic acids
10/27/2011WO2011131193A1 Diagnosing and treating fibrotic diseases using micro-rna 17
10/27/2011WO2011131151A1 Liquid chip for detecting pik3ca gene mutations
10/27/2011WO2011131149A1 Liquid chip for detecting kras gene mutation
10/27/2011WO2011131146A1 Specific primers and liquid chips for detecting braf gene mutation
10/27/2011WO2011131145A1 Liquid chip for detecting egfr gene mutations
10/27/2011WO2011130895A1 Promoter siubi1, preparation method and uses thereof
10/27/2011WO2011130894A1 Promoter sbubi1, preparation method and uses thereof
10/27/2011WO2011130893A1 Promoter sbubi2, preparation method and uses thereof
10/27/2011WO2011130878A1 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
10/27/2011WO2011130836A1 Cell-based production of nonulosonates
10/27/2011WO2011130815A2 Method for promoting an exacerbated increase in vegetable biomass
10/27/2011WO2011113015A3 Antisense modulation of nuclear hormone receptors
10/27/2011WO2011109524A3 Xylanase variants and polynucleotides encoding same
10/27/2011WO2011104155A3 Plants having enhanced yield-related traits and a method for making the same
10/27/2011WO2011103154A3 A green tissue-preferred promoter from maize
10/27/2011WO2011084455A3 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
10/27/2011WO2011084387A3 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof
10/27/2011WO2011084314A3 Novel bacillus thuringiensis gene with coleopteran activity
10/27/2011WO2011083344A3 Antimicrobial peptides
10/27/2011WO2011081421A9 Complement c9 as markers for the diagnosis of cancer
10/27/2011WO2011072205A3 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin)
10/27/2011WO2011071956A3 Method for identification of protease activity inhibitors and assaying the presence of protease activity
10/27/2011WO2011069227A8 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/27/2011WO2011066467A3 Allelic ladder loci
10/27/2011WO2011057288A3 Isobutanol production with corynebacterium glutamicum
10/27/2011WO2011057160A3 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
10/27/2011WO2011056005A3 Novel sirna structure for minimizing off-target effects caused by antisense strands, and use thereof
10/27/2011WO2011055897A3 Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same
10/27/2011WO2011049418A9 Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof
10/27/2011WO2011049322A3 Method for detecting methylation of breast cancer-specific methylation marker gene for breast cancer diagnosis
10/27/2011WO2011044469A3 Diagnostic methods for oral cancer
10/27/2011WO2011038205A3 Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh
10/27/2011WO2011037414A3 Recombinant mutant microorganism with increased alcohol production ability, and preparation method of alcohol using same
10/27/2011WO2010091149A8 Modification of multidomain enzyme for expression in plants
10/27/2011US20110265226 Improved production of proteins with downstream box fusions in plastids and in bacteria
10/27/2011US20110265225 Transgenic plant having increased seed size
10/27/2011US20110265224 Control of so2 metabolism in plants and its applications
10/27/2011US20110265222 Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
10/27/2011US20110265221 Transgenic plants with enhanced agronomic traits
10/27/2011US20110265220 Squash hybrid px 13067464
10/27/2011US20110265219 Pepper hybrid ps09930066
10/27/2011US20110265218 Soybean cultivar 90210442
10/27/2011US20110265217 Soybean Cultivar 98331422
10/27/2011US20110265216 Soybean Cultivar 1000682
10/27/2011US20110265215 Soybean cultivar 1000681
10/27/2011US20110265214 Soybean Cultivar 95330721
10/27/2011US20110265213 Soybean Cultivar 90282601
10/27/2011US20110265212 Soybean Cultivar 97032301
10/27/2011US20110265211 Soybean Cultivar 94334045
10/27/2011US20110265210 Soybean Cultivar 98164635
10/27/2011US20110265209 Soybean Cultivar S090249
10/27/2011US20110265208 Soybean cultivar s090245
10/27/2011US20110265207 Soybean Cultivar 95062025
10/27/2011US20110265206 Soybean cultivar s090246
10/27/2011US20110265205 Soybean Cultivar S090248
10/27/2011US20110265204 Soybean cultivar 93022415
10/27/2011US20110265203 Soybean cultivar 94222415
10/27/2011US20110265202 Engineering of plants to exhibit self-compatibility
10/27/2011US20110265201 White-stem trait containing plants
10/27/2011US20110265199 Nucleotide sequences and polypeptides encoded thereby useful for increasing tolerance to oxidative stress in plants
10/27/2011US20110265198 Genome editing of a Rosa locus using nucleases
10/27/2011US20110265196 Penaeidin gene promoters in tiger shrimp and applications thereof
10/27/2011US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011US20110265194 Them5-modified models of non-alcoholic fatty liver disease
10/27/2011US20110265192 Nuclear receptor sensor system in transgenic animal
10/27/2011US20110264375 Computer-assisted means for assessing lifestyle risk factors
10/27/2011US20110263835 Recombinant nell protein production
10/27/2011US20110263824 Modified biotin-binding protein
10/27/2011US20110263822 Composition for the prophylaxis and treatment of hbv infections and hbv-mediated diseases
10/27/2011US20110263820 Antibodies and processes for preparing the same
10/27/2011US20110263690 Methods and Compositions for use in Gene Therapy for Treatment of Hemophilia
10/27/2011US20110263689 AKT Ligands and Polynucleotides Encoding AKT Ligands
10/27/2011US20110263687 Rna molecules and uses thereof
10/27/2011US20110263686 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/27/2011US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011US20110263683 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
10/27/2011US20110263682 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53
10/27/2011US20110263679 C12orf48 as a target gene for cancer therapy and diagnosis
10/27/2011US20110263678 Inhibitors of tgf-r signaling for treatment of cns disorders
10/27/2011US20110263675 Methods of modulating mesenchymal stem cell differentiation
10/27/2011US20110263585 Screening Assay for Insecticides
10/27/2011US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity
10/27/2011US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011US20110263488 Family of pesticidal proteins and methods for their use
10/27/2011US20110263484 Single chain fc type iii interferons and methods of using same
10/27/2011US20110263483 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/27/2011US20110263482 Complement inhibitors
10/27/2011US20110263460 Compositions and methods for producing replication competent human immunodeficiency virus (hiv)
10/27/2011US20110263459 Direct selection of structurally defined aptamers
10/27/2011US20110263436 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same